Genprex (GNPX) Prices 7.62M Share Common Offering at $1.05/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
- SanDisk upgraded at JPMorgan after investor day; shares climb
Genprex (GNPX) Adds to Tuesday's Big Gains on FDA News; Shares Up 60%
January 22, 2020 8:33 AM ESTGenprex (NASDAQ: GNPX) adds to Tuesday gains after the company received DA Fast Track designation for its gene therapy that targets lung cancer. Shares are up 64% pre-open after gaining 219% on Tuesday.
... MoreGenprex (GNPX) Granted FDA Fast Track Designation for Gene Therapy that Targets Lung Cancer
January 21, 2020 8:01 AM ESTGenprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor... More
